CH101ZZ
Planar Nuclear Medicine Imaging Breast, Right to None with None, Technetium 99m (Tc-99m) Approach
Procedural Specifications
| Clinical Axis | Detail Definition |
|---|---|
| Section | C Nuclear Medicine |
| Body System | H Skin, Subcutaneous Tissue and Breast |
| Operation | 1 Planar Nuclear Medicine Imaging |
| Body Part | 0 Breast, Right |
| Approach | 1 Technetium 99m (Tc-99m) |
| Device | Z None |
| Qualifier | Z None |
Operation Definition
Introduction of radioactive materials into the body for single plane display of images developed from the capture of radioactive emissions
Procedure Overview
This family covers single-plane radioactive imaging of the skin, subcutaneous tissue, and breast, most commonly lymphoscintigraphy performed to map lymphatic drainage before breast cancer or melanoma surgery. A radioactive tracer, typically technetium-99m sulfur colloid, is injected near the tumor or biopsy site, and a gamma camera captures flat images as the tracer travels through lymphatic channels toward the first draining lymph nodes.
Surgeons use these images to identify and mark the sentinel lymph node, the first node a tumor would spread to, so it can be removed and examined during surgery instead of removing an entire chain of lymph nodes unnecessarily. The scan is typically done the same day as surgery or the day before, and the images are often paired with a handheld gamma probe used in the operating room to physically locate the marked node.
Anatomy & Axis Detail
Breast, Right
Planar imaging of the right breast most often supports lymphoscintigraphy for sentinel lymph node mapping in breast cancer staging, where a radiotracer injected near a tumor site is tracked as it drains toward axillary or internal mammary nodes. Because breast tissue overlies the chest wall and pectoral musculature, positioning and marker placement are documented carefully to correlate tracer accumulation with surgical landmarks. The two-dimensional planar technique produces a single flattened image per view, adequate for confirming nodal drainage pathways without the cross-sectional detail of tomographic acquisition. Laterality matters clinically since findings guide unilateral surgical planning, and the right-sided code applies specifically when the procedure and resulting image pertain only to the right breast.
Radionuclide: Technetium 99m (Tc-99m)
Technetium 99m (Tc-99m) is the most widely used radionuclide in Nuclear Medicine, valued for its short half-life and favorable gamma energy for imaging bone, cardiac, renal, and other organ systems. In this axis position it records that a technetium-based radiopharmaceutical was the tracer administered for the study, distinguishing it from the many other specific isotopes, such as thallium or iodine compounds, used for more specialized indications.
Coding & Documentation
A code from this family requires documentation of the tracer injection near the breast or skin lesion and confirmation that flat, single-position images were obtained showing lymphatic drainage pathways and node uptake, without a rotational SPECT component. The most frequent coding error is applying this code when only the intraoperative gamma probe was used to find the node, since the probe-guided localization without preceding preoperative planar imaging does not meet this root operation. Another common mistake is misclassifying the body system when the drainage pattern documented actually centers on a lymph node basin elsewhere in the body rather than the breast or skin site itself.
Commonly Confused With
This family is frequently confused with Tomographic Nuclear Medicine Imaging when a SPECT/CT lymphoscintigraphy was performed instead of a planar-only study, since SPECT/CT gives better anatomic localization in obese patients or complex drainage patterns. It is also distinguished from Lymphatic and Hemic System nuclear medicine imaging, which applies when the primary structure being evaluated is a lymph node group unrelated to a breast or skin lesion rather than the drainage from a skin or breast site.